XML 41 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Income Taxes
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
8.
Income Taxes
 
No
provision for federal and state income tax expense has been recorded for the years ended
December 
31,
 
2019
and
2018
due to the valuation allowance recorded against the net deferred tax asset and recurring losses.
 
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows at
December 
31,
 
2019
and
2018:
 
   
2019
   
2018
 
Deferred income tax assets:
               
Tax loss carryforwards
  $
42,107,372
    $
30,239,898
 
Deferred revenue
   
     
1,856,507
 
Research and development credits
   
3,016,889
     
2,382,047
 
Stock-based compensation
   
973,905
     
489,694
 
Lease liability
   
1,508,645
     
 
Compensation
   
564,572
     
431,649
 
Fixed assets
   
     
160,784
 
Patent amortization
   
86,985
     
97,942
 
Other
   
55,972
     
669,151
 
Valuation allowance
   
(47,505,967
)    
(36,327,672
)
Total deferred income tax assets
   
808,373
     
 
Deferred income tax liabilities:
               
Fixed assets
   
158,787
     
 
Operating leases
   
649,586
     
 
Total deferred income tax liabilities
   
808,373
     
 
Total net deferred tax
  $
    $
 
 
 
As of
December 
31,
 
2019
and
2018,
the Company established a full valuation allowance against its net deferred tax assets since, at the time, the Company could
not
assert that it was more likely than
not
that its deferred tax assets would be realized. As a result, there was an increase in the valuation allowance in
2019
of
$11,178,295.
 
As of
December 
31,
 
2019,
the Company had federal and state income tax loss carryforwards of
$97,268,927
and
$184,191,027,
respectively, which begin to expire in
2024
for federal purposes and in
2019
for state purposes. As of
December 31, 2019,
the Company had federal and state income tax loss carryforwards of
$85,765,810
and
$778,925,
respectively, which carryforward indefinitely. In addition, the Company has tax credit carryforwards for federal tax purposes of
$3,175,600
as of
December 
31,
 
2019,
which begin to expire in
2026.
The utilization of net operating loss and tax credit carryforwards to reduce future income taxes will depend on the Company’s ability to generate sufficient taxable income prior to the expiration of the loss carryforwards.
 
The Internal Revenue Code of
1986,
as amended, contains provisions which limit the ability to utilize the net operating loss carryforwards in the case of certain events, including significant changes in ownership interests. If the Company’s net operating loss carryforwards are limited, and the Company has taxable income which exceeds the permissible yearly net operating loss carryforwards, the Company would incur a federal income tax liability even though net operating loss carryforwards would be available in future years.
 
The reasons for the difference between actual income tax expense for the years ended
December 
31,
 
2019
and
2018
and the amount computed by applying the statutory federal income tax rate to income before income tax are as follows:
 
   
2019
   
2018
 
   
 
 
 
 
% of Pretax
   
 
 
 
 
% of Pretax
 
   
Amount
   
Earnings
   
Amount
   
Earnings
 
Income tax benefit at statutory rate
  $
(10,019,974
)    
21.0
%
  $
(11,158,530
)    
21.0
%
State income taxes, net of federal tax benefit
   
(957,616
)    
2.0
     
(1,062,492
)    
2.0
 
Non-deductible expenses
   
94,903
     
(0.2
)    
6,810
     
 
Stock-based compensation
   
258,338
     
(0.5
)    
10,925
     
 
Non-deductible interest expense
   
     
     
4,074,501
     
(7.7
)
Derivative and warrant fair value adjustments
   
     
     
(63,873
)    
0.1
 
Credits
   
(634,842
)    
1.3
     
     
 
Change in state rate
   
3,887
     
     
(2,842
)    
 
Other
   
77,009
     
(0.1
)    
(139,660
)    
0.3
 
Change in valuation allowance
   
11,178,295
     
(23.5
)    
8,335,161
     
(15.7
)
Provision for income taxes
  $
     
0.0
%
  $
     
0.0
%
 
 
The Company has determined that there
may
be a future limitation on the Company’s ability to utilize its entire federal R&D credit carryover. Therefore, the Company recognized an uncertain tax benefit associated with the federal R&D credit carryover during the years ended
December 
31,
2019
and
2018,
as follows:
 
Balance at December 31, 2017
  $
 
Increases related to 2018
   
 
Increases related to prior periods
   
 
Balance at December 31, 2018
   
 
Increases related to 2019
   
158,710
 
Increases related to prior periods
   
 
Balance at December 31, 2019
  $
158,710
 
 
 
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than
not
that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The Company has determined that it had
no
other material uncertain tax benefits for the year ended
December 
31,
2019.The
Company’s policy for recording interest and penalties related to uncertain tax provisions is to record them as a component of the provision for income taxes. The Company did
not
have any accrued interest or penalties associated with any unrecognized tax positions as of
December 
31,
 
2019
and
2018,
and there were
no
such interest or penalties recognized during the years ended
December 
31,
 
2019
and
2018.
 
The Company has all tax years open to examination by federal tax and state tax jurisdictions.
No
income tax returns are currently under examination by taxing authorities.